Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stents | 4 | 2023 | 491 | 2.310 |
Why?
|
| Alloys | 2 | 2023 | 29 | 1.650 |
Why?
|
| Radiography, Interventional | 2 | 2024 | 74 | 1.520 |
Why?
|
| Iliac Vein | 2 | 2022 | 9 | 1.420 |
Why?
|
| Catheter Ablation | 2 | 2022 | 154 | 1.330 |
Why?
|
| Vascular Diseases | 2 | 2021 | 81 | 1.320 |
Why?
|
| Contrast Media | 3 | 2023 | 424 | 0.950 |
Why?
|
| Infusions, Intra-Arterial | 2 | 2024 | 13 | 0.940 |
Why?
|
| Stellate Ganglion | 1 | 2024 | 5 | 0.920 |
Why?
|
| Cryosurgery | 1 | 2024 | 29 | 0.910 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 297 | 0.880 |
Why?
|
| Portal Vein | 1 | 2024 | 38 | 0.870 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2024 | 1618 | 0.820 |
Why?
|
| Tachycardia, Ventricular | 1 | 2024 | 129 | 0.780 |
Why?
|
| Thyroid Nodule | 1 | 2022 | 14 | 0.780 |
Why?
|
| Vena Cava Filters | 1 | 2022 | 23 | 0.770 |
Why?
|
| Vena Cava, Inferior | 1 | 2022 | 33 | 0.760 |
Why?
|
| Venous Insufficiency | 1 | 2021 | 5 | 0.750 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2022 | 58 | 0.750 |
Why?
|
| Epilepsy | 3 | 2022 | 113 | 0.740 |
Why?
|
| Radiology | 2 | 2023 | 252 | 0.730 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 71 | 0.730 |
Why?
|
| Embolization, Therapeutic | 1 | 2024 | 318 | 0.680 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 115 | 0.680 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 43 | 0.670 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 58 | 0.660 |
Why?
|
| Arthritis, Infectious | 1 | 2019 | 20 | 0.640 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 11 | 0.640 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 79 | 0.640 |
Why?
|
| Prosthesis-Related Infections | 1 | 2019 | 34 | 0.630 |
Why?
|
| Lymphography | 3 | 2023 | 11 | 0.590 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5657 | 0.570 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6631 | 0.550 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 126 | 0.550 |
Why?
|
| Humans | 29 | 2024 | 63298 | 0.460 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 319 | 0.430 |
Why?
|
| Radiology, Interventional | 2 | 2023 | 32 | 0.370 |
Why?
|
| Sheep | 2 | 2022 | 179 | 0.360 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2024 | 97 | 0.350 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 129 | 0.340 |
Why?
|
| Biomechanical Phenomena | 2 | 2022 | 270 | 0.330 |
Why?
|
| Hepatic Artery | 2 | 2024 | 20 | 0.270 |
Why?
|
| Water | 3 | 2023 | 309 | 0.250 |
Why?
|
| Pandemics | 2 | 2020 | 673 | 0.240 |
Why?
|
| Middle Aged | 6 | 2024 | 17551 | 0.220 |
Why?
|
| Liver Regeneration | 1 | 2024 | 19 | 0.220 |
Why?
|
| Time Factors | 2 | 2024 | 3762 | 0.220 |
Why?
|
| Animals | 5 | 2023 | 20631 | 0.220 |
Why?
|
| Male | 8 | 2024 | 29819 | 0.210 |
Why?
|
| Tarsal Bones | 1 | 2023 | 3 | 0.210 |
Why?
|
| Ventricular Fibrillation | 1 | 2024 | 106 | 0.210 |
Why?
|
| Female | 9 | 2024 | 32789 | 0.210 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 1649 | 0.210 |
Why?
|
| Minnesota | 1 | 2023 | 41 | 0.210 |
Why?
|
| Vascular Patency | 1 | 2023 | 139 | 0.200 |
Why?
|
| Aged | 3 | 2024 | 14392 | 0.200 |
Why?
|
| Mentors | 1 | 2023 | 119 | 0.190 |
Why?
|
| Prosthesis Design | 1 | 2023 | 227 | 0.190 |
Why?
|
| Swine | 1 | 2023 | 374 | 0.190 |
Why?
|
| Consciousness | 1 | 2022 | 12 | 0.190 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2022 | 23 | 0.190 |
Why?
|
| Angioplasty | 1 | 2022 | 51 | 0.190 |
Why?
|
| Device Removal | 1 | 2022 | 67 | 0.190 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 221 | 0.180 |
Why?
|
| Awareness | 1 | 2022 | 74 | 0.180 |
Why?
|
| Saphenous Vein | 1 | 2021 | 52 | 0.180 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2021 | 24 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 1084 | 0.170 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 13 | 0.170 |
Why?
|
| Sus scrofa | 1 | 2020 | 29 | 0.170 |
Why?
|
| Sternum | 1 | 2020 | 29 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 280 | 0.170 |
Why?
|
| Leptospermum | 1 | 2020 | 1 | 0.170 |
Why?
|
| Phloroglucinol | 1 | 2020 | 2 | 0.170 |
Why?
|
| Sesquiterpenes | 1 | 2020 | 15 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 288 | 0.170 |
Why?
|
| Gases | 1 | 2019 | 21 | 0.160 |
Why?
|
| Disease Progression | 1 | 2024 | 1168 | 0.160 |
Why?
|
| Cervical Vertebrae | 1 | 2020 | 114 | 0.160 |
Why?
|
| Self Report | 1 | 2022 | 374 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2022 | 477 | 0.160 |
Why?
|
| Spinal Fusion | 1 | 2020 | 148 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 663 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 183 | 0.140 |
Why?
|
| STAT4 Transcription Factor | 1 | 2017 | 8 | 0.140 |
Why?
|
| Cognition | 1 | 2022 | 484 | 0.140 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 38 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 172 | 0.140 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 113 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 210 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 224 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2017 | 120 | 0.130 |
Why?
|
| Spatial Behavior | 1 | 2014 | 9 | 0.110 |
Why?
|
| Space Perception | 1 | 2014 | 19 | 0.110 |
Why?
|
| Consciousness Disorders | 1 | 2014 | 10 | 0.110 |
Why?
|
| Risk Factors | 1 | 2024 | 5341 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 97 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2014 | 125 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 2180 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2014 | 54 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2020 | 800 | 0.100 |
Why?
|
| Intracranial Hemorrhages | 2 | 2024 | 67 | 0.100 |
Why?
|
| Radiography | 2 | 2023 | 548 | 0.090 |
Why?
|
| Canada | 2 | 2021 | 155 | 0.080 |
Why?
|
| Tranexamic Acid | 1 | 2024 | 7 | 0.060 |
Why?
|
| Antifibrinolytic Agents | 1 | 2024 | 16 | 0.060 |
Why?
|
| Adult | 4 | 2024 | 16782 | 0.050 |
Why?
|
| Infusion Pumps | 1 | 2023 | 8 | 0.050 |
Why?
|
| Edema | 1 | 2023 | 43 | 0.050 |
Why?
|
| Ethiodized Oil | 1 | 2023 | 7 | 0.050 |
Why?
|
| Child | 2 | 2023 | 4522 | 0.050 |
Why?
|
| Radiologists | 1 | 2023 | 88 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2024 | 738 | 0.050 |
Why?
|
| Immunoproteins | 1 | 2021 | 1 | 0.050 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 46 | 0.050 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 21 | 0.040 |
Why?
|
| Ketones | 1 | 2020 | 5 | 0.040 |
Why?
|
| Benzophenones | 1 | 2020 | 18 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 264 | 0.040 |
Why?
|
| Textiles | 1 | 2020 | 10 | 0.040 |
Why?
|
| Diskectomy | 1 | 2020 | 36 | 0.040 |
Why?
|
| Masks | 1 | 2020 | 23 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 45 | 0.040 |
Why?
|
| Embolectomy | 1 | 2019 | 15 | 0.040 |
Why?
|
| Biomimetics | 1 | 2020 | 30 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 168 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 384 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1396 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 169 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 190 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Germinal Center | 1 | 2017 | 40 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 80 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 178 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 462 | 0.030 |
Why?
|
| Polymers | 1 | 2020 | 323 | 0.030 |
Why?
|
| Health Personnel | 1 | 2021 | 367 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 174 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 972 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 566 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 620 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 735 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 2164 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 4683 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2037 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2074 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1348 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1617 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3391 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1001 | 0.020 |
Why?
|
| United States | 1 | 2020 | 7829 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 10827 | 0.010 |
Why?
|